BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31433156)

  • 21. Multifunctional nanogel engineering with redox-responsive and AIEgen features for the targeted delivery of doxorubicin hydrochloride with enhanced antitumor efficiency and real-time intracellular imaging.
    Ma Y; Zhou H; Hu F; Pei Z; Xu Y; Shuai Q
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S900-S910. PubMed ID: 30371105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin.
    Pang Z; Gao H; Yu Y; Guo L; Chen J; Pan S; Ren J; Wen Z; Jiang X
    Bioconjug Chem; 2011 Jun; 22(6):1171-80. PubMed ID: 21528923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'Dendrimer-Cationized-Albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin.
    Muniswamy VJ; Raval N; Gondaliya P; Tambe V; Kalia K; Tekade RK
    Int J Pharm; 2019 Jan; 555():77-99. PubMed ID: 30448308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiopep2-functionalized polymersomes for targeted doxorubicin delivery to glioblastoma cells.
    Figueiredo P; Balasubramanian V; Shahbazi MA; Correia A; Wu D; Palivan CG; Hirvonen JT; Santos HA
    Int J Pharm; 2016 Sep; 511(2):794-803. PubMed ID: 27484836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity.
    Singh RK; Patel KD; Mahapatra C; Parthiban SP; Kim TH; Kim HW
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):288-299. PubMed ID: 30539634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron-silicate-coated porous silicon nanoparticles for in situ ROS self-generation.
    Um H; Kang RH; Kim D
    Colloids Surf B Biointerfaces; 2023 May; 225():113273. PubMed ID: 36965332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted delivery of tumor suppressor microRNA-1 by transferrin-conjugated lipopolyplex nanoparticles to patient-derived glioblastoma stem cells.
    Wang X; Huang X; Yang Z; Gallego-Perez D; Ma J; Zhao X; Xie J; Nakano I; Lee LJ
    Curr Pharm Biotechnol; 2014; 15(9):839-46. PubMed ID: 25374033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transferrin/aptamer conjugated mesoporous ruthenium nanosystem for redox-controlled and targeted chemo-photodynamic therapy of glioma.
    Zhu X; Zhou H; Liu Y; Wen Y; Wei C; Yu Q; Liu J
    Acta Biomater; 2018 Dec; 82():143-157. PubMed ID: 30316026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photothermal and biodegradable polyaniline/porous silicon hybrid nanocomposites as drug carriers for combined chemo-photothermal therapy of cancer.
    Xia B; Wang B; Shi J; Zhang Y; Zhang Q; Chen Z; Li J
    Acta Biomater; 2017 Mar; 51():197-208. PubMed ID: 28069501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.
    Sandbhor P; Goda J; Mohanty B; Gera P; Yadav S; Chekuri G; Chaudhari P; Dutt S; Banerjee R
    Drug Deliv Transl Res; 2023 Feb; 13(2):608-626. PubMed ID: 36245060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porous Silicon Nanocarriers with Stimulus-Cleavable Linkers for Effective Cancer Therapy.
    Xue Y; Bai H; Peng B; Tieu T; Jiang J; Hao S; Li P; Richardson M; Baell J; Thissen H; Cifuentes A; Li L; Voelcker NH
    Adv Healthc Mater; 2022 Jun; 11(12):e2200076. PubMed ID: 35306736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy.
    Amreddy N; Muralidharan R; Babu A; Mehta M; Johnson EV; Zhao YD; Munshi A; Ramesh R
    Int J Nanomedicine; 2015; 10():6773-88. PubMed ID: 26604751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immobilized transferrin Fe3O4@SiO2 nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery.
    Ding W; Guo L
    Int J Nanomedicine; 2013; 8():4631-9. PubMed ID: 24348038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transferrin-modified Doxorubicin-loaded biodegradable nanoparticles exhibit enhanced efficacy in treating brain glioma-bearing rats.
    Liu G; Mao J; Jiang Z; Sun T; Hu Y; Jiang Z; Zhang C; Dong J; Huang Q; Lan Q
    Cancer Biother Radiopharm; 2013 Nov; 28(9):691-6. PubMed ID: 23786401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanobody-displaying porous silicon nanoparticles for the co-delivery of siRNA and doxorubicin.
    Tieu T; Wojnilowicz M; Huda P; Thurecht KJ; Thissen H; Voelcker NH; Cifuentes-Rius A
    Biomater Sci; 2021 Jan; 9(1):133-147. PubMed ID: 33135714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.
    Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z
    Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
    Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Biasibetti E; Capucchio MT; Valazza A; Panciani PP; Lanotte M; Schiffer D; Annovazzi L; Caldera V; Mellai M; Riganti C
    J Pharm Sci; 2014 Jul; 103(7):2157-2165. PubMed ID: 24824141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Domino-Like Intercellular Delivery of Undecylenic Acid-Conjugated Porous Silicon Nanoparticles for Deep Tumor Penetration.
    Yong T; Hu J; Zhang X; Li F; Yang H; Gan L; Yang X
    ACS Appl Mater Interfaces; 2016 Oct; 8(41):27611-27621. PubMed ID: 27653799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo.
    Zhong Y; Wang C; Cheng R; Cheng L; Meng F; Liu Z; Zhong Z
    J Control Release; 2014 Dec; 195():63-71. PubMed ID: 25108151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.